Pharmaceutical Manufacturers Grapple With ICH Q3D Implementation
Executive Summary
Pharmaceutical manufacturers say that complying with ICH Q3D presents a host of challenges, and that the more difficult task is conducting a risk assessment rather than actual testing for elemental impurities. Companies are finding that they should allow plenty of time for risk assessments.